$2.8B to scare the tar out of you

What’s a sure-fire way to see your physician’s expression change? During your visit, simply say “I was looking on WebMD yesterday and now I think [fill in the blank].” WebMD is one of the most valuable healthcare internet properties and soon you won’t be able to buy its stock. KKR (massive private equity firm) announced this week that it is buying WebMD for $2.8B. WebMD gets most of its revenue from advertisers—and pharma companies are among the largest spenders. But that has dropped off, prompting WebMD to look for options. We suspect KKR is banking on an increase in new drug approvals (read – advertising money) to improve WebMD’s financials. That, and a pharma-friendly FDA wouldn’t hurt either.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn